Medicare program; end-stage renal disease prospective payment system and quality incentive program; ambulance fee schedule; durable medical equipment; and competitive acquisition of certain durable medical equipment prosthetics, orthotics and suppli
about
Evaluation of the consumer assessment of healthcare providers and systems in-center hemodialysis surveyThe comparative short-term effectiveness of iron dosing and formulations in US hemodialysis patients.Intravenous iron supplementation practices and short-term risk of cardiovascular events in hemodialysis patientsTrends in anemia management in US hemodialysis patients 2004-2010Has dialysis payment reform led to initial racial disparities in anemia and mineral metabolism management?Completeness of Methicillin-Resistant Staphylococcus aureus Bloodstream Infection Reporting From Outpatient Hemodialysis Facilities to the National Healthcare Safety Network, 2013Reduced use of erythropoiesis-stimulating agents and intravenous iron with ferric citrate: a managed care cost-offset model.International Comparisons to Assess Effects of Payment and Regulatory Changes in the United States on Anemia Practice in Patients on Hemodialysis: The Dialysis Outcomes and Practice Patterns Study.Net Budgetary Impact of Ferric Citrate as a First-Line Phosphate Binder for the Treatment of Hyperphosphatemia: A Markov Microsimulation ModelFacility Practice Variation to Help Understand the Effects of Public Policy: Insights from the Dialysis Outcomes and Practice Patterns Study (DOPPS).Comparative Effectiveness of Dialyzers: A Longitudinal, Propensity Score-Matched Study of Incident Hemodialysis Patients.Process evaluation of the RaDIANT community study: a dialysis facility-level intervention to increase referral for kidney transplantation.Weekly Standard Kt/Vurea and Clinical Outcomes in Home and In-Center Hemodialysis.
P2860
Q33715836-C048402F-D7D0-44E9-AC9A-BEA986F12CF3Q33832885-A1EEE666-97AC-4A7B-9A45-7A034B75C66AQ35041088-5F24ECD0-11D5-4D3D-BB8C-0A8903952648Q35056402-94663AE9-1D5A-4ADA-AD32-4FED26E299AEQ35124228-773E75F1-1D72-4053-84E5-1E0EF24B0A4CQ36755816-4560A9BA-E9D9-4921-8177-451C74049DE9Q36825820-BB4D0466-6E06-44EA-97F3-7FA9DEDEDBC2Q37052058-8F593482-70B9-42B2-84EC-574440D85F33Q37653426-30DC33E7-235D-4685-A886-8771E764E950Q39034880-41DB5F51-6EDB-4A25-A9A6-6238499D9005Q41008520-117375C6-1C94-4B63-B0A3-809226C7B1B4Q47559336-5645B885-0032-409A-B45A-E89D1B0EEA54Q48257514-60101155-1C90-4CD5-A8DC-676DE6C4D779
P2860
Medicare program; end-stage renal disease prospective payment system and quality incentive program; ambulance fee schedule; durable medical equipment; and competitive acquisition of certain durable medical equipment prosthetics, orthotics and suppli
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Medicare program; end-stage re ...... sthetics, orthotics and suppli
@en
type
label
Medicare program; end-stage re ...... sthetics, orthotics and suppli
@en
prefLabel
Medicare program; end-stage re ...... sthetics, orthotics and suppli
@en
P1433
P1476
Medicare program; end-stage re ...... sthetics, orthotics and suppli
@en
P304
70228-70316
P577
2011-11-01T00:00:00Z